Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis

David Gent; José Miguel Rivera‐Caravaca; Rebecca Dobson; David Wright; Professor Gregory Lip

doi:10.1016/j.ejim.2022.09.016

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Stephanie L. Harrison, Elnara Fazio‐Eynullayeva, Deirdre A. Lane, Paula Underhill, Professor Gregory Lip

Article2018

Electronic Cigarette Prevalence and Patterns of Use in Adults with a History of Cardiovascular Disease in the United States

Andrew Stokes, Jason M. Collins, Kaitlyn M. Berry, Lindsay M. Reynolds, Jessica L. Fetterman, Carlos J. Rodríguez, Michael Siegel, Emelia Benjamin

Article2020

A Blockchain-Based Credibility Scoring Framework for Electronic Medical Records

S Siva Rama Krishnan, M Manoj, Thippa Reddy Gadekallu, Neeraj Kumar, Praveen Kumar Reddy Maddikunta, Sweta Bhattacharya, Doug Young Suh, Md. Jalil Piran

Article2024

Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis

Joséphine Mayer, Gashirai K. Mbizvo, Tommaso Bucci, Anthony G Marson, Professor Gregory Lip

Article2023

Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada

Anees Bahji, Josh Hathaway, Denise Adams, David Crockford, E. Jennifer Edelman, Michael D. Stein, Scott Burton Patten